Article
Targeting Cblb-Notch1 axis as a novel immunotherapeutic strategy to boost CD8+ T-cells…
medRxiv · 2022 · Giulia Monticone
Key facts
| Title | Targeting Cblb-Notch1 axis as a novel immunotherapeutic strategy to boost CD8+ T-cells responses |
|---|---|
| First author | Giulia Monticone |
| Journal | medRxiv |
| Published | Mar 16, 2022 |
| DOI | 10.1101/2022.03.15.484378 |
| Devices mentioned | K073490 |
| Product codes mentioned | CFN, JQP |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1